Truxima and Mycophenolate mofetil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Truxima (rituximab-abbs) and Mycophenolate mofetil (mycophenolate mofetil). Common drug interactions include arthralgia among females.

The phase IV clinical study analyzes what interactions people have when they take Truxima and Mycophenolate mofetil. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Truxima?

Truxima has active ingredients of rituximab-abbs. eHealthMe is studying from 4,063 Truxima users. Check the latest studies of Truxima.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.



On Jul, 26, 2026

23 people who take Truxima and Mycophenolate mofetil together, and have interactions are studied.

Truxima and Mycophenolate mofetil drug interactions.

What are the common drug interactions of Truxima and Mycophenolate Mofetil, by gender? *:

female:

  1. Arthralgia (joint pain)
  2. Arthropathy
  3. Peripheral swelling
  4. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  5. Rash
  6. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  7. Sciatica (a set of symptoms including pain caused by general compression or irritation of one of five spinal nerve roots of each sciatic nerve)
  8. Sinusitis (inflammation of sinus)
  9. Synovitis (inflammation of the synovial membrane)
  10. Weight increased

male:

n/a

What are the common drug interactions of Truxima and Mycophenolate Mofetil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Ill-defined disorder
  2. Impaired healing
  3. Infection
  4. Inflammation
  5. Infusion related reaction
  6. Injury
  7. Irritable bowel syndrome
  8. Joint range of motion decreased (disease of joint movement)
  9. Joint swelling
  10. Knee arthroplasty

50-59:

n/a

60+:

  1. Alanine aminotransferase increased
  2. Anaphylactic reaction (serious allergic reaction)
  3. Blood pressure increased
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. C-reactive protein increased
  6. Cataract (clouding of the lens inside the eye)
  7. Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)
  8. Cystitis (inflammation of the wall of the bladder)
  9. Diarrhoea
  10. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)

What are the existing conditions these people have? *

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 13 people, 56.52%
  2. Diabetes: 8 people, 34.78%
  3. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 6 people, 26.09%
  4. Stress And Anxiety: 6 people, 26.09%
  5. Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 5 people, 21.74%
  6. Urticaria (rash of round, red welts on the skin that itch intensely): 3 people, 13.04%
  7. Inflammation: 3 people, 13.04%
  8. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder): 3 people, 13.04%
  9. Eosinophilic Fasciitis (a skin disease that causes thickening and inflammation of the skin and fascia): 3 people, 13.04%
  10. Fever: 3 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Truxima and Mycophenolate mofetil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Truxima and Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Truxima:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Truxima and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mycophenolate mofetil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rituximab-abbs and mycophenolate mofetil (the active ingredients of Truxima and Mycophenolate mofetil, respectively), and Truxima and Mycophenolate mofetil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: